When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. CHA2DS2–VASc score - Wikipedia

    en.wikipedia.org/wiki/CHA2DS2–VASc_score

    The European Society of Cardiology (ESC), [21] and National Institute for Health and Care Excellence (NICE) [23] guidelines recommend that if the patient has a CHA 2 DS 2-VASc score of 2 and above, oral anticoagulation therapy (OAC) with a vitamin K antagonist (VKA, e.g. warfarin with target INR of 2-3) or one of the direct oral anticoagulant ...

  3. HAS-BLED - Wikipedia

    en.wikipedia.org/wiki/HAS-BLED

    HAS-BLED is a scoring system developed to assess 1-year risk of major bleeding in people taking anticoagulants for atrial fibrillation (AF). It was developed in 2010 with data from 3,978 people in the Euro Heart Survey. [1]

  4. Vitamin K antagonist - Wikipedia

    en.wikipedia.org/wiki/Vitamin_K_antagonist

    The term "vitamin K antagonist" is technically a misnomer, as the drugs do not directly antagonize the action of vitamin K in the pharmacological sense, but rather the recycling of vitamin K. Vitamin K antagonists (VKAs) have been the mainstay of anticoagulation therapy for more than 50 years.

  5. A very small glass of wine might be good for the heart, study ...

    www.aol.com/wine-may-good-heart-study-000542140.html

    Drinking under a glass of wine a day while on the Mediterranean diet might help the heart, a new study finds. Experts aren’t so sure.

  6. Factbox-Countries' guidance on alcohol consumption

    www.aol.com/news/factbox-countries-guidance...

    National Health Service guidelines recommend consuming no more than 14 units of alcohol per week. The service, which is publicly funded, advises "there's no completely safe level of drinking, but ...

  7. Get the latest news, politics, sports, and weather updates on AOL.com.

  8. Dabigatran - Wikipedia

    en.wikipedia.org/wiki/Dabigatran

    Dabigatran is used to prevent strokes in those with atrial fibrillation not caused by heart valve issues, as well as deep vein thrombosis and pulmonary embolism in persons who have been treated for 5–10 days with parenteral anticoagulant (usually low molecular weight heparin), and to prevent deep vein thrombosis and pulmonary embolism in some circumstances.

  9. Hypercoagulability in pregnancy - Wikipedia

    en.wikipedia.org/wiki/Hypercoagulability_in...

    The main issue with anticoagulation in pregnancy is that warfarin, the most commonly used anticoagulant in chronic administration, is known to have teratogenic effects on the fetus if administered in early pregnancy. [11] [12] Still, there seems to be no teratogenic effect of warfarin before six weeks of gestation. [13]